Miyake and Masakatsu Yamashita has discovered that Bach2, a protein essential for regulating T cells function, plays a crucial role in the remission of atopic dermatitis symptoms. These findings ...

Atopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to social stress. In socially active adults, the disease often becomes chronic.

Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for ...

Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...

There are a variety of treatment options available for managing atopic dermatitis (AD). Topical corticosteroids remain the gold standard of care, while phototherapy and immunosuppressants may be ...

Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ...

Explore holistic approaches to treating the atopic triad in children—eczema, asthma, and allergies—with naturopathic ...

The ability to achieve complete IRAK4 degradation and cytokine suppression in disease-relevant tissues such as synovial ... superior therapeutic benefits for chronic inflammatory diseases including ...